by Kameron Hodges, RN
In March, a 70-year-old man came to the Clinic with a chronic, and at times life-threatening, condition that kept a dangerous bacteria lingering in his system. When active, the bacteria caused severe inflammation and swelling, fevers, and skin lesions. At its worst, the offender crept into his bloodstream, causing a life-threatening condition known as sepsis. He had battled this unknown bacterial assailant for more than 9 years before it was identified in September 2011 as Burkholderiapseudomallei (also known as Pseudomonas pseudomallei).
The bacterium is so rarely found in the North American continent that only four to five cases are reported annually in the United States. Additionally, it is often resistant to antibiotic treatment. Once the bacterium was identified, the mainstream medical community prescribed and administered some of its most powerful front-line antibiotics, Vancomycin and Meropenem. He was informed, by a confident infectious disease specialist, that his condition was cured but that he would need to keep a potent antibiotic prescription on hand at all times, just in case. Within four months, the gentleman was back in the hospital for a five-day stay being infused with IV antibiotics.
Once at the Riordan Clinic, a thorough medical history, focused assessment, and series of laboratory tests were completed. While his white blood cell count was within normal limits (he was free of an active infection) his C-reactive protein, an indication of inflammatory levels, was found to be nearly double the normal value. His vitamin D level was also significantly diminished. A treatment plan was developed that called for the patient to receive ultraviolet blood irradiation (UBI) and oral vitamin D supplementation. UBI, also known as Biophotonic Therapy (BPT), photoluminescence, photopheresis, and photodynamic therapy, is a process of exposing blood to ultraviolet light to stimulate the immune system to first destroy and then to develop antibody defenses to viral, bacterial, and fungal pathogens.
After the second UBI treatment, the patient regained the ability to breathe through his right sinus passage, something he had not been able to do in almost 50 years, and following the fourth treatment, his vision became noticeably sharper. The patient continued having UBI treatments twice a week, and after the fifth treatment, was able to come off the daily antibiotics, which over the years had become the key to keeping him infection free and out of the hospital. The patient has expressed extreme excitement over his treatment and progress. He has been free of infection for more than 150 days, something previously unattainable without daily antibiotic use. He states that he is feeling better than he has in years. His C-reactive protein level is also now within normal limits.
UBI therapy is currently available to new and existing Riordan Clinic patients and treats a multitude of conditions including but not limited to: chronic fatigue, fibromyalgia, hepatitis, respiratory infections, non-healing wounds, chronic yeast and urinary tract infections, asthma and allergies, rheumatoid arthritis, staph and MRSA infections, shingles and herpes, poor circulation, lupus and heart disease.
Other benefits UBI can provide include: improvement in circulation and oxygenation of tissues, balancing effect (homeostasis), reduction in tissue pain, increased tolerance of the body to radiation or chemotherapy, cardiovascular protection through increased metabolism of cholesterol, uric acid, and glucose, anti-inflammatory effects, powerful anti-infection properties, stimulation of red blood cells and improvement in the flow and properties of the blood.